Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( (HK:2563) ) just unveiled an update.
Beijing Biostar Pharmaceuticals Co., Ltd. has announced a virtual board meeting scheduled for June 27, 2025, to discuss and approve the company’s consolidated annual results for the year ended December 31, 2024. The meeting will also consider the recommendation for a final dividend payment and address other business matters, which could impact the company’s financial strategies and shareholder returns.
More about Beijing Biostar Pharmaceuticals Co., Ltd. Class H
Beijing Biostar Pharmaceuticals Co., Ltd. is a pharmaceutical company based in China, focusing on the development and production of biopharmaceutical products.
Average Trading Volume: 345,688
Technical Sentiment Signal: Strong Sell
See more data about 2563 stock on TipRanks’ Stock Analysis page.